These findings indicate that inhibiting the IL-33/ST2 pathway in BV2 cells may exacerbate cognitive impairment in part by impairing Aβ clearance, with LD accumulation potentially contributing to this effect. This evidence concerns the gene IL33 and Cognitive impairment.